Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 0.250% 1/1
-
Number of holders
-
31
-
Total 13F principal, excl. options
-
293,181,906
-
Principal change
-
-19,764,594
-
Total reported value, excl. options
-
$250,805,827
-
Value change
-
-$23,948,051
-
Number of buys
-
14
-
Number of sells
-
-19
-
Price
-
$0.8541
Significant Holders of NEOGENOMICS INC - NOTE 0.250% 1/1 as of Q4 2021
39 filings reported holding 64049MAB6 - NEOGENOMICS INC - NOTE 0.250% 1/1 as of Q4 2021.
NEOGENOMICS INC - NOTE 0.250% 1/1 has 31 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $293,181,906 of principal
.
Largest 10 bondholders include Linden Advisors LP ($94,192,000 of principal), CALAMOS ADVISORS LLC ($53,220,000 of principal), CITADEL ADVISORS LLC ($23,500,000 of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($21,497,000 of principal), Jefferies Group LLC ($13,764,000 of principal), PUTNAM INVESTMENTS LLC ($12,635,000 of principal), FRANKLIN RESOURCES INC ($12,500,000 of principal), DEUTSCHE BANK AG\ ($10,078,000 of principal), BANK OF AMERICA CORP /DE/ ($7,138,000 of principal), and BNP PARIBAS ARBITRAGE, SA ($6,586,000 of principal).
This table shows the top 31 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.